BlueCrest Capital Management Ltd purchased a new position in HCA Healthcare Inc (NYSE:HCA) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 16,622 shares of the company’s stock, valued at approximately $1,460,000.
Other institutional investors and hedge funds also recently modified their holdings of the company. Glenhill Advisors LLC purchased a new position in HCA Healthcare during the 4th quarter valued at about $27,247,000. Lyrical Asset Management LP purchased a new position in HCA Healthcare during the 4th quarter valued at about $324,051,000. Focused Wealth Management Inc purchased a new position in HCA Healthcare during the 4th quarter valued at about $257,000. Scotia Capital Inc. purchased a new position in HCA Healthcare during the 4th quarter valued at about $2,024,000. Finally, Parallel Advisors LLC grew its stake in HCA Healthcare by 76.2% during the 4th quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock valued at $117,000 after acquiring an additional 578 shares in the last quarter. 73.48% of the stock is currently owned by hedge funds and other institutional investors.
In related news, insider Charles J. Hall sold 49,882 shares of the business’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $101.29, for a total value of $5,052,547.78. Following the completion of the sale, the insider now directly owns 62,048 shares in the company, valued at approximately $6,284,841.92. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Bill B. Rutherford sold 48,462 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $102.42, for a total value of $4,963,478.04. Following the completion of the sale, the chief financial officer now owns 41,269 shares of the company’s stock, valued at $4,226,770.98. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 482,318 shares of company stock valued at $48,394,005. Corporate insiders own 2.90% of the company’s stock.
HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.87 by $0.25. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The firm had revenue of $11.56 billion during the quarter, compared to analyst estimates of $11.19 billion. During the same period in the previous year, the company earned $1.80 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. analysts predict that HCA Healthcare Inc will post 8.71 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, March 30th. Investors of record on Thursday, March 1st will be issued a $0.35 dividend. The ex-dividend date is Wednesday, February 28th. This represents a $1.40 annualized dividend and a yield of 1.35%. HCA Healthcare’s dividend payout ratio (DPR) is currently 20.68%.
Several equities analysts have weighed in on HCA shares. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 target price on the stock. in a research note on Wednesday, December 20th. Bank of America cut HCA Healthcare from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $94.00 to $90.00 in a research note on Thursday, January 4th. Credit Suisse Group reaffirmed an “outperform” rating and set a $25.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 26th. Robert W. Baird set a $104.00 target price on HCA Healthcare and gave the company a “buy” rating in a research note on Friday, January 12th. Finally, Goldman Sachs Group started coverage on HCA Healthcare in a research note on Wednesday, January 3rd. They set a “neutral” rating on the stock. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $104.50.
TRADEMARK VIOLATION WARNING: “BlueCrest Capital Management Ltd Invests $1.46 Million in HCA Healthcare Inc (HCA) Stock” was first published by Markets Daily and is the property of of Markets Daily. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.themarketsdaily.com/2018/03/13/bluecrest-capital-management-ltd-invests-1-46-million-in-hca-healthcare-inc-hca-stock.html.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.